黑色素瘤发病率和死亡率的趋势
Milaan Shah1, Nina Schur2, Angela Rosenberg3
1Department of Dermatology, Medical University of South Carolina, Charleston, SC 29425, USA.
Dermatologic clinics
|June 28, 2025
概括
黑色素瘤的发病率和死亡率正在上升,尽管治疗方面取得了进展. 这项研究考察了性别,年龄,种族,社会经济地位和浴床使用等因素如何影响各种人群中的这些趋势.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 流行病学 流行病学
背景情况:
- 黑色素瘤是全球癌症死亡的重要原因之一.
- 尽管有治疗和诊断方面的改进,黑色素瘤的发病率和死亡率每年都在不断上升.
- 许多因素,包括患者的人口统计和生活方式选择,影响黑色素瘤的结果.
研究的目的:
- 分析黑色素瘤发病率和死亡率的趋势.
- 研究可修改变量对黑色素瘤结局的影响.
- 为了检查不同亚种群的黑色素瘤趋势.
主要方法:
- 黑色素瘤数据的流行病学分析.
- 对发病率和死亡率的统计检查.
- 根据人口和社会经济因素对数据进行分层.
主要成果:
- 观察到黑色素瘤发病率和死亡率每年增加.
- 在不同性别,年龄组,种族和社会经济地位之间发现了黑色素瘤发病率的显著差异.
- 浴床的使用与黑色素瘤风险的改变有关.
结论:
- 黑色素瘤仍然是一个日益严重的公共卫生问题.
- 了解人口和生活方式的影响对于有针对性的预防和治疗策略至关重要.
- 对可修改的风险因素进行进一步的研究是有必要的,以制黑色素瘤流行病.
相关概念视频
Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
Prevalence and Incidence
833
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
833
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Kaplan-Meier Approach
277
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
277
Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


